Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GC 1126A

X
Drug Profile

GC 1126A

Alternative Names: GC-1126A

Latest Information Update: 06 Oct 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GC Pharma
  • Developer GC Biopharma
  • Class Recombinant proteins
  • Mechanism of Action ADAMTS protein modulators; Autoantibody inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Thrombotic thrombocytopenic purpura
  • New Molecular Entity Yes
  • Available For Licensing Yes - Thrombotic thrombocytopenic purpura

Highest Development Phases

  • Preclinical Thrombotic thrombocytopenic purpura

Most Recent Events

  • 05 Oct 2023 Preclinical trials in Thrombotic thrombocytopenic purpura in South Korea (unspecified route)
  • 27 Sep 2023 GC 1126A receives Orphan Drug status for Thrombotic thrombocytopenic purpura in USA
  • 29 Mar 2022 GC Pharma is now called GC Biopharma

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top